Kestra Medical Technologi... (KMTS)
Kestra Medical Technologies Ltd. (KMTS) Stock Price, Analysis & Data
| Bid | 20.52 |
| Market Cap | 1.64B |
| Revenue (ttm) | 95.13M |
| Net Income (ttm) | -131.61M |
| Beta | n/a |
| EPS (ttm) | -2.43 |
| PE Ratio (ttm) | n/a |
| Forward PE | -13.86 |
| P/B (ttm) | 6.30 |
| P/S (ttm) | 17.25 |
| Earnings Date | Sep 14, 2026 |
| Ask | 28.1 |
| Volume | 397,600 |
| Avg. Volume (20D) | 371,998 |
| Open | 27.76 |
| Previous Close | 27.90 |
| Day's Range | 27.53 - 28.59 |
| 52-Week Range | 15.06 - 30.00 |
| Analyst | Strong Buy |
| Price Target | 30 (7.14%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About KMTS
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac a...
Financial Performance
In 2026, Kestra Medical's revenue was 95.13M, an increase of 59.03% compared to the previous year's 59.81M. Earnings were -131.61M, an increase of 15.64%.
Financial StatementsAnalyst Forecast
According to 7 analyst ratings, the average rating for KMTS stock is "Strong Buy". The 12-month stock price forecast is 30, which is upside of 7.14% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
